Gilead Sciences, Inc.
US ˙ NasdaqGS ˙ US3755581036

SecurityGILD / Gilead Sciences, Inc.
InstitutionBlackRock Variable Series Funds, Inc. - BlackRock Managed Volatility V.I. Fund Class I
Latest Disclosed Ownership2,056 shares
Latest Disclosed Value $ 227,948
BlackRock Variable Series Funds, Inc. - BlackRock Managed Volatility V.I. Fund Class I reports 43.27% decrease in ownership of GILD / Gilead Sciences, Inc.

On August 28, 2025 - BlackRock Variable Series Funds, Inc. - BlackRock Managed Volatility V.I. Fund Class I filed a NPORT-P form disclosing ownership of 2,056 shares of Gilead Sciences, Inc. (US:GILD) valued at $227,949 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 27, 2025 disclosing 3,624 shares of Gilead Sciences, Inc.. This represents a change in shares of -43.27% during the quarter. The current value of the position is $268,102 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-28 2025-06-30 NP Gilead Sciences EC US3755581036 2,056 -1,568 -43.27 228 -44.09 0.1501
2025-05-27 2025-03-31 NP Gilead Sciences EC US3755581036 3,624 1,895 109.60 406 155.35 0.2710
2025-02-27 2024-12-31 NP Gilead Sciences EC US3755581036 1,729 -952 -35.51 160 -29.02 0.0987
2024-11-26 2024-09-30 NP Gilead Sciences EC US3755581036 2,681 -1,047 -28.08 225 -12.16 0.1382
2024-08-27 2024-06-30 NP Gilead Sciences EC US3755581036 3,728 -501 -11.85 256 -17.48 0.1547
2024-05-28 2024-03-31 NP Gilead Sciences EC US3755581036 4,229 -387 -8.38 310 -17.16 0.1809
2024-02-27 2023-12-31 NP Gilead Sciences EC US3755581036 4,616 1,501 48.19 374 60.09 0.2243
2023-11-22 2023-09-30 NP Gilead Sciences EC US3755581036 3,115 1,111 55.44 233 51.30 0.1404
2023-08-25 2023-06-30 NP Gilead Sciences EC US3755581036 2,004 -1,818 -47.57 154 -51.42 0.0903
2023-05-26 2023-03-31 NP Gilead Sciences EC US3755581036 3,822 -33 -0.86 317 -3.94 0.1873
2023-02-24 2022-12-31 NP Gilead Sciences EC US3755581036 3,855 -588 -13.23 331 20.44 0.1901
2022-11-28 2022-09-30 NP Gilead Sciences EC US3755581036 4,443 -690 -13.44 274 -13.56 0.1609
2022-08-26 2022-06-30 NP Gilead Sciences EC US3755581036 5,133 -504 -8.94 317 -5.37 0.1781
2022-05-25 2022-03-31 NP Gilead Sciences EC US3755581036 5,637 1,231 27.94 335 5.02 0.1691
2022-02-25 2021-12-31 NP Gilead Sciences EC US3755581036 4,406 503 12.89 320 17.28 0.1489
2021-11-26 2021-09-30 NP Gilead Sciences EC US3755581036 3,903 1,088 38.65 273 40.93 0.1248
2021-08-24 2021-06-30 NP Gilead Sciences EC US3755581036 2,815 276 10.87 194 17.68 0.0880
2021-05-25 2021-03-31 NP Gilead Sciences EC US3755581036 2,539 -1,035 -28.96 164 -21.15 0.0748
2021-02-24 2020-12-31 NP Gilead Sciences EC US3755581036 3,574 117 3.38 208 -4.59 0.0931
2020-11-24 2020-09-30 NP Gilead Sciences EC US3755581036 3,457 -730 -17.43 218 -32.30 0.1033
2020-08-24 2020-06-30 NP Gilead Sciences EC US3755581036 4,187 -2,506 -37.44 322 -35.60 0.1543
2020-05-26 2020-03-31 NP Gilead Sciences EC US3755581036 6,693 962 16.79 500 34.41 0.2464
2020-02-25 2019-12-31 NP Gilead Sciences EC 375558103 5,731 -2,994 -34.32 372 -32.61 0.1576
2019-11-25 2019-09-30 NP Gilead Sciences EC US3755581036 8,725 8,725 553 0.2352
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.